Clinical trial

TAXUS PERSEUS Small Vessel

NCT00489541 · Boston Scientific Corporation, Industry · Completed

Key facts

NCT number NCT00489541
Title TAXUS PERSEUS Small Vessel
Official title A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels
Acronym PERSEUS SV
Lead sponsor Boston Scientific Corporation, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions Percutaneous Coronary Intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation
Enrollment 224
Start date Jul 1, 2007
Primary completion Jun 1, 2009
Completion Oct 1, 2013
First posted Jun 21, 2007
Last update posted May 8, 2014
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies